Small Molecule Targeted Cancer Therapy Market -
Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 -
2019
Small molecule targeted cancer
therapies are drugs designed to block the growth of cancerous cells.
Conventional cytotoxic medications and chemotherapies usually destroys rapidly
dividing cancer cells by inhibiting cell division process. However, small
molecule targeted therapies destroys cancerous cells with fewer side effects
and high precision. Small molecule targeted cancer therapies can be used for
the treatment of various cancers such as prostate cancer, multiple myeloma,
breast cancer, lymphoma, melanoma and other cancers.
Visit Complete Report Here: http://www.marketresearchreports.biz/analysis-details/small-molecule-targeted-cancer-therapy-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Targeted cancer drugs are broadly
classified as follows:
- Small Molecules
- Monoclonal Antibodies
- Small Molecule Drug conjugates
Small molecules can further be
classified as follows:
- Small molecule proteasome
inhibitor (e.g. Bortezomib)
- Small molecule
cyclin-dependent kinase inhibitor (e.g. Seliciclib)
- Small molecule tyrosine kinase
inhibitor (e.g. Imatinib)
Geographically, North America is
the leading market due to the rise incancer cases. According to the International
Agency for Research on Cancer (IARC), around 13 million new cancer cases has
been diagnosed worldwide. Moreover, according to the World Cancer Report,
incidence rate of cancer could further rise by 50% to 15 million new cancer
cases by 2020. Furthermore, the European and Asian-Pacific regions are
expected to witness increased market traction due to commercialization of
target oriented economic drugs.
The major factors driving this
market are rise in incidence rate of cancer, minimal adverse effects, targeted
approach and high adoption rate. Additionally, more number of blockbuster
drugs such as Novartis’s Glivec are losing their patents, leaving significant
opportunities for manufacturers of targeted cancer drugs. However, high
developmental costs, stringent regulatory policies andlow awareness are some
of the restraints that could impede the growth of the market.
Some of the market players in this
industry segment are Abbott Laboratories, Bayer HealthCare AG, Boehringer
Ingelheim GmbH, CytokineticsInc., GlaxoSmithKline plc, Hospira Inc. ,
OncoGenex Pharmaceuticals Inc., and others.
This research report analyzes this
market depending on its market segments, major geographies, and current market
trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive
analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for
upcoming years
This report is a complete study of
current trends in the market, industry growth drivers, and restraints. It
provides market projections for the coming years. It includes analysis of
recent developments in technology, Porter’s five force model analysis and
detailed profiles of top industry players. The report also includes a review
of micro and macro factors essential for the existing market players and new
entrants along with detailed value chain analysis.
Reasons for Buying this Report
- This report provides pin-point
analysis for changing competitive dynamics
- It provides a forward looking
perspective on different factors driving or restraining market growth
- It provides a technological
growth map over time to understand the industry growth rate
- It provides a seven-year
forecast assessed on the basis of how the market is predicted to
grow
- It helps in understanding the
key product segments and their future
- It provides pin point analysis
of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed
business decisions by having complete insights of market and by making
in-depth analysis of market segments
- It provides distinctive
graphics and exemplified SWOT analysis of major market segments
Contact US:
Office: United States
|
State Tower
90 State Street, Suite 700 Albany, NY 12207 United States |
No comments:
Post a Comment